Anti-CD31 Antibodies: Expanding Applications in Oncology and Biomedical Research
The Anti-CD31 Antibody Market is expanding as pharmaceutical companies, research institutes, clinical laboratories, and academic organizations use CD31-targeting antibodies in cancer research, vascular biology, diagnostics, and therapeutic development.
According to Wise Guy Reports, the Anti-CD31 Antibody Market was valued at USD 1 billion in 2024 and is expected to grow from USD 1.1 billion in...